Biomerica BMRA
NASDAQ BMRA
$1.59 +0.07 (+4.82%)
At close: Aug 20, 2026 · 1:51 PM UTC

Biomerica (BMRA) Invested Capital (2011 - 2012)

Biomerica (BMRA) posted Invested Capital of $43000.0 for Q2 2012, up 266.21% sequentially from $11742.0 in Q4 2011, and up 21.5% YoY from $35390.0 in Q2 2011.

Biomerica (BMRA) Invested Capital (2011 - 2012) Analysis & Trends

Biomerica has reported Invested Capital for 2 years, with the latest figure at $43000.0 in Q2 2012.

  • Quarterly Invested Capital rose 21.5% year-over-year to $43000.0 in Q2 2012, while the trailing twelve-month figure through Feb 2013 was $43000.0 (down 39.26% YoY) and the FY2012 annual result came in at $43000.0, up 21.5% from the prior year.
  • Invested Capital climbed to $43000.0 in Q2 2012 per BMRA's latest filing, from $11742.0 in the prior quarter.
  • Over five years, Invested Capital peaked at $43000.0 in Q2 2012 and troughed at $11742.0 in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 199.46 Bn 193.86 Bn 7.27 Bn 3.01 Bn
2 Stryker 127.41 Bn 123.93 Bn 4.50 Bn 750.00 Mn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn 1.71 Bn
5 Edwards Lifesciences 51.95 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.30 Bn 32.35 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 2.00 Mn
8 Koninklijke Philips 26.35 Bn 23.02 Bn 4.55 Bn 1.34 Bn
9 Steris 23.04 Bn 22.55 Bn 684.20 Mn 243.40 Mn
10 Biomerica 4.79 Mn 3.45 Mn -44,000.00 -

Historic Data

Download Data
DateValue
May 31, 2012 43,000.00
Nov 30, 2011 11,742.00
Aug 31, 2011 23,664.00
May 31, 2011 35,390.00